70 related articles for article (PubMed ID: 9844450)
1. [Study of costs associated with catheter-related bacteremia].
Morís de la Tassa J; Fernández Muñoz P; Antuña Egocheaga A; Gutiérrez del Río MC; de la Fuente García B; Cartón Sánchez JA
Rev Clin Esp; 1998 Oct; 198(10):641-6. PubMed ID: 9844450
[TBL] [Abstract][Full Text] [Related]
2. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
3. [Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs].
Peña C; Pujol M; Pallarés R; Corbella X; Vidal T; Tortras N; Ariza J; Gudiol F
Med Clin (Barc); 1996 Mar; 106(12):441-4. PubMed ID: 8656728
[TBL] [Abstract][Full Text] [Related]
4. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study.
Kothari A; Sagar V; Ahluwalia V; Pillai BS; Madan M
J Hosp Infect; 2009 Feb; 71(2):143-8. PubMed ID: 19058876
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
Blot SI; Depuydt P; Annemans L; Benoit D; Hoste E; De Waele JJ; Decruyenaere J; Vogelaers D; Colardyn F; Vandewoude KH
Clin Infect Dis; 2005 Dec; 41(11):1591-8. PubMed ID: 16267731
[TBL] [Abstract][Full Text] [Related]
6. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Crnich CJ
Am J Infect Control; 2003 Dec; 31(8):475-80. PubMed ID: 14647110
[TBL] [Abstract][Full Text] [Related]
7. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
[TBL] [Abstract][Full Text] [Related]
8. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
9. [The estimation of the cost of nosocomial infection in an intensive care unit].
Díaz Molina C; García Martín M; Bueno Cavanillas A; López Luque A; Delgado Rodríguez M; Gálvez Vargas R
Med Clin (Barc); 1993 Mar; 100(9):329-32. PubMed ID: 8455410
[TBL] [Abstract][Full Text] [Related]
10. Thoracic aortic aneurysm repair. Direct hospital cost and Diagnosis Related Group reimbursement.
Mishra V; Geiran O; Krohg-Sørensen K; Andresen S
Scand Cardiovasc J; 2008 Feb; 42(1):77-84. PubMed ID: 18273734
[TBL] [Abstract][Full Text] [Related]
11. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Safdar N
Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
[TBL] [Abstract][Full Text] [Related]
12. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.
Caballero-Granado FJ; Becerril B; Cuberos L; Bernabeu M; Cisneros JM; Pachón J
Clin Infect Dis; 2001 Feb; 32(4):587-94. PubMed ID: 11181122
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Schwaber MJ; Navon-Venezia S; Kaye KS; Ben-Ami R; Schwartz D; Carmeli Y
Antimicrob Agents Chemother; 2006 Apr; 50(4):1257-62. PubMed ID: 16569837
[TBL] [Abstract][Full Text] [Related]
14. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
15. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
16. [Estimating the costs associated with nosocomial urinary tract infection. A case-control study].
Morís de la Tassa J; Fernández Muñoz P; Antuña Egocheaga A; Gutiérrez del Río MC; Cartón Sánchez JA
Rev Clin Esp; 2003 Mar; 203(3):119-24. PubMed ID: 12646079
[TBL] [Abstract][Full Text] [Related]
17. Estimating hospital costs attributable to prolonged air leak in pulmonary lobectomy.
Varela G; Jiménez MF; Novoa N; Aranda JL
Eur J Cardiothorac Surg; 2005 Feb; 27(2):329-33. PubMed ID: 15691691
[TBL] [Abstract][Full Text] [Related]
18. [Nosocomial bacteremia in the adult patient. Study of associated costs].
Morano Amado LE; Del Campo Pérez V; López Miragaya I; Martínez Vázquez MJ; Vázquez Alvarez O; Pedreira Andrade JD
Rev Clin Esp; 2002 Sep; 202(9):476-84. PubMed ID: 12236937
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality.
Liu JW; Su YK; Liu CF; Chen JB
J Hosp Infect; 2002 Mar; 50(3):224-7. PubMed ID: 11886200
[TBL] [Abstract][Full Text] [Related]
20. Institutional perspective on the impact of positive blood cultures on the economic and clinical outcomes of patients with complicated skin and skin structure infections: focus on gram-positive infections.
Micek ST; Hoban AP; Pham V; Doherty JA; Kollef MH
Clin Ther; 2011 Nov; 33(11):1759-1768.e1. PubMed ID: 22001358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
